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Abstract
How to realize targeted photoacoustic imaging, enhanced immunotherapy, and photothermal therapy of gastric
cancer has become a great challenge. Herein, we reported for the first time that human cytokine-induced killer cells
(CIK) loaded with gold nanorods were used for targeted photoacoustic imaging, enhanced immunotherapy, and
photothermal therapy of gastric cancer. Silica-modified gold nanorods were prepared; then incubated with human
cytokine-induced killer cells (CIK), resultant human CIK cells loaded with Au nanorods were evaluated for their
cytotoxicity, targeted ability of gastric cancer in vitro and in vivo, immunotherapy, and photothermal therapy
efficacy. In vitro cell experiment shows that human CIK cells labeled with gold nanorods actively target gastric
cancer MGC803 cells, inhibit growth of MGC803 cells by inducing cell apoptosis, and kill MGC803 cells under low
power density near-infrared (NIR) laser treatment (808-nm continuous wave laser, 1.5 W/cm2, 3 min). In vivo
experiment results showed that human CIK cells labeled with gold nanorods could target actively and image
subcutaneous gastric cancer vessels via photoacoustic imaging at 4 h post-injection, could enhance immunotherapy
efficacy by up-regulating cytokines such as IL-1, IL-12, IL-2, IL-4, IL-17, and IFN-γ, and kill gastric cancer tissues by
photothermal therapy via direct injection into tumor site under near-infrared (NIR) laser irradiation. High-performance
human CIK cells labeled with Au nanorods are a good novel theranostic platform to exhibit great potential in
applications such as tumor-targeted photoacoustic imaging, enhanced immunotherapy, and photothermal therapy in
the near future.
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Background
Gastric cancer is the fourth commonest cancer and the
second leading cause of cancer-related death worldwide
[1–3]. It ranks number two among all malignant tumors
in China according to the latest cancer disease spectrum
[4]. The gastric cancer patient prognosis is very poor
with 5-year survivals below 24 % [5]. How to cure com-
pletely gastric cancer has become a great challenge.
Cellular immunotherapy has become a promising thera-
peutic method to fight against cancers and is classified as
class III medical treatment technology since 2009 in China
[6–9]. Among various cellular immunotherapy methods,
lymph cytokine activated killer (LAK) cells were firstly used
for anti-cancer therapy by Elizabeth A. Grimm [10]. Then,
Joseph H. Phillips finished a further research of the oncoly-
tic effects executed by LAK cells. A kind of more powerful
anti-tumor cell–tumor-infiltrating lymphocytes (TIL) were
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reported in 1986. After 5 years, Schmidt-Wolf invented a
new culture method of cytokine-induced killer (CIK)
cells—a better cellular immunotherapy than LAK cells and
TIL. They kill tumor cells mainly via CD3+CD56+ cell mass
[10–14]. Current reports show that CIK cells own the
ability to target in vivo tumor cells [15, 16], homing
to the tumor site through vascular perfusion. And the
targeting characteristic of CIK cells has extensive
adaptability feature, which may be applied to clinical
tumor therapy. However, up to date, few reports have
demonstrated that tumor patients with middle and
late stages can be cured completely by using DCs and
CIK immunotherapies. How to enhance CIK thera-
peutic effects has become a challengeable problem.
Therefore, it is very necessary to develop new thera-
peutic strategies that could enhance CIK therapeutic
effects and/or improve synergistic combined therapy.
Up to date, gold nanoparticle-based theranostics has
achieved great advances for cancer prevention, imaging,
and therapy [17–20]. For example, gold nanorods
(GNRs) have caused more attention due to their unique
optical properties and the potential applications. So far,
various shapes of gold nanoparticles have been prepared,
such as gold nanospheres, gold nanorods, gold nanopr-
isms (Au NPrs), gold nanostars, gold nanoshells, and
gold nanowires [21–23], which strongly decide their dif-
ferent applications such as photothermal therapy (PTT)
[24–26], photoacoustic imaging [27–29], and surface-
enhanced resonance spectroscopy (SERS) [30]. Espe-
cially, gold nanorods have a relative bigger specific
surface area to display an obvious surface plasmon res-
onance (SPR) band in the near-infrared (NIR) region of
the electromagnetic (EM) spectrum and can be excited to
produce heat efficiently [31, 32]. More important, the NIR
radiation has a deeper penetration depth in biological tis-
sues, which makes it an excellent theranostic agent for
medical applications such as photoacoustic imaging and
photothermal therapy (PTT) [33–35]. In our previous
work, we realized controlled synthesis of gold nanorods
and used gold nanorods to realize tumor targeting im-
aging, enhanced radiotherapeutic efficacy, and photother-
mal therapy [36, 37]. Due to gold nanorods’ good
biocompatibility, we consider that gold nanorods have
their own clinical translation prospect [18].
In this study, we fully take the advantages of human
CIK cells and gold nanorods, with the aim of enhancing
synergistic CIK cell therapeutic effects combined with
PTT of gold nanorods. as in Scheme 1, we prepared hu-
man CIK cells, synthesized silica-modified gold nanorods,
then prepared human CIK cells loaded with Au nanorods,
and investigated the feasibility of human CIK cells loaded
with Au nanorods for tumor targeting and PTT. Our re-
sults show that human CIK cells loaded with Au nanorods
could target gastric cancer in vivo, realized photoacoustic
imaging and enhanced immunotherapy, as well as photo-
thermal therapy of gastric cancer, markedly enhanced CIK
therapeutic efficacy. Our results provide a new strategy to
treat gastric cancer, offer proof-of-principle of practicality
of CIK combined with PTT based on human CIK cells
loaded with gold nanorods, and exhibit potential clinical
applications such as theranostics of gastric cancer and
post-operation tumor patients and highly efficient delivery
system for gene or drugs in near future.
Methods
All animal experiments were approved by the Institu-
tional Animal Care and Use Committee of Shanghai Jiao
Tong University (SCXK-2012-0002).
Material Source
Gold chloride trihydrate (HAuCl4 · 4H2O, 99 %), sodium
borohydride (NaBH4), silver nitrate (AgNO3), L-ascorbic
Scheme 1 Schematic Illustration of preparation of human CIK cells loaded with gold nanorods and their applications in vivo
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acid, and ethanol were obtained from Sinopharm Chemical
Reagent Company (Shanghai, China). N-Cetyltrimethylam-
monium bromide (CTAB) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Tetraethyl orthosilicate
(TEOS) was purchased from Aladdin Reagent Co. Ltd
(Shanghai, China). DiO perchlorate [3,3-dioctadecyloxacar
bocyanine perchlorate], DiI iodide [1,1-dioctadecyl-3,3,3,3-
tetramethylindocarbocyanine iodide], and DiR iodide [1,1-
dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide]
were obtained from AAT Bioquest Inc. (America). Annexin
V-FITC/PI Apoptosis Detection Kit and Cell Counting Kit-
8 (CCK-8) were purchased from Yeasen Corporation
(Shanghai, China). MGC803 cell line and GES-1 cell line
were available in the Cell Bank of Type Culture Collection
of Chinese Academy of Sciences. Cytokine-induced killer
cells were extracted from peripheral blood (PB) of healthy
volunteers in our laboratory. Cell culture products and re-
agents, unless mentioned otherwise, were purchased from
GIBCO. All the above chemicals were used without any
further purification. Milli-Q water (18.2 MΩcm, Millipore
Co., USA) was used in all the preparations. Serum-free X-
VIVO15 medium was purchased from LONZA (USA).
Recombinant human IL-2 (rhIL-2) was purchased from
Invitrogen Corporation (GIBCO, USA). Anti-human CD3ε
monoclonal antibody (CD3 mAb, OKT3) was purchased
from Nobimpex (Germany). Recombinant human IFN-γ
(rh IFN-γ) was obtained from Shanghai Clonbiotech Co.,
LTD (China).
Synthesis and Characterization of Gold Nanorods
Gold nanorods were synthesized according to our previ-
ous report [22, 35]. The concrete steps are as follows: in
brief, seed gold particles were formed by adding pre-iced
aqueous NaBH4 (0.01 M, 600 μL) into the mix aqueous
CTAB (0.1 M, 7.5 mL) and HAuCl4 (24.3 mM, 102.9 μL)
rapidly while stirring. Then, the solution was stirred dra-
matically for 2 min and kept completely stationary at
30 °C for 2 h. Then, an aqueous solution (100 mL) of
HAuCl4 (24.3 mM, 1.030 mL), AgNO3 (0.01 M, 1 mL),
and CTAB (0.1 M, 100 mL) was treated with fresh ascor-
bic acid (0.1 M, 400 μL) and the solution changed color
from bright yellow to colorless under vigorous stirring.
The growth solution was then treated with a freshly pre-
pared Au NP seed solution (3–5 nm; 0.24 ml) and began
to turn red within 30 min. The end product was allowed
to stand at room temperature overnight to yield a 100-
mL suspension of GNRs with a longitudinal plasmon
resonance (LPR) centered at 810 nm.
Preparation and Characterization of Silica-Coated Au
Nanorods
The prepared Au NRs (10 mL) were subjected to centri-
fugation at 10,000 rpm for 10 min and separated from
the supernatant, then redispersed in Milli-Q water to a
final volume of 10 mL. Then, 15 μL of 1 M NaOH solu-
tion was added under equably stirring to adjust the PH
to 10.0. Following this step, 400 μL 10 mM TEOS in
ethanol was added under gentle stirring per 30-min in-
tervals (three times in total). The mixture was reacted
for 24 h at 30 °C with gentle stirring. UV–vis spectra of
Au NRs and Au NR@SiO2 nanoparticles were measured
with a Varian Cary 50 spectrophotometer (Varian Inc.,
Palo Alto, CA, USA) equipped with a 10-mm quartz cell,
where the light path length was 1 cm. The sizes and
morphologies of the nanoparticles were characterized by
high-resolution transmission electron microscope
(HRTEM) on JEM-2100F (JEOL, Japan) with an acceler-
ation voltage of 200 kV.
Isolation, Culture, Expansion, and Phenotype Analysis of
CIK Cells
By using a blood cell separator (Spectra v 6.1, Cobe,
USA), (2–4) × 109 PBMC cells from each healthy volun-
teer were obtained in a total volume of 50 mL. Cellular
concentration was adjusted to 2 × 106/mL in fresh
serum-free X-VIVO 15 medium and incubated at 37 °C
in a humidified atmosphere of 5 % CO2. To generate
CIK cells, 2000 U/mL rh IFN-γ was added on the initial
day. After 24 h of incubation, 50 ng/mL CD3 mAb and
1000 U/mL rhIL-2 were added. Fresh IL-2 and fresh X-
VIVO 15 media were replenished every 3 days. On day
0, 4, 7, 10, 13, and 15, cell densities were determined. In-
cubated CIK cells (day 18) were collected, washed, and
stained with anti-CD3-FITC and anti-CD56-PE anti-
bodies (Becton Dickinson, USA). Cells were incubated
with Abs for 30 min at 4 °C, and then the stained cells
were washed and analyzed by BD FACSCalibur (BD Bio-
sciences, Mountain View, CA). The CIK cells were col-
lected on day 18 for DiR labeling and co-incubated with
silica-modified Au nanorods.
Cytotoxicity Analysis of Silica-Modified Au Nanorods by
CCK-8 Assay
The MGC803 and GES-1 cells were maintained at 37 °C
(5 % CO2) in Dulbecco’s Modified Eagle’s Medium
(DMEM, HyClone) supplemented with 10 % (vol/vol)
fetal bovine serum, 100 U mL−1 penicillin and
0.1 mg mL−1 streptomycin. Cell counting kit-8 (CCK-8)
assay was carried out to investigate the toxicity of Au
NR@SiO2 nanoparticles. In brief, MGC803 cells, GES-1
cells, and CIK cells were seeded in 96-well plate at a
density of 5 × 103 cells per well and cultured for 24 h.
The cells in each well were incubated with 100-μL
complete medium containing serial concentrations of
Au NR@SiO2 nanoparticles (0~36 culture. After 24 h of
incubation, 10 μL sterile CCK-8 per well was added and
continued to incubate for 2 h at 37 °C (5 % CO2). The
optical density values were determined at least in
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triplicate against a reagent blank at a test wavelength of
450 nm and reference wavelength of 630 nm.
Then, the human CIK cells labeled with silica-
modified Au nanorods were collected and treated, the
contents of Au in human CIK cells were measured by
BIO-TEM (120-kV biology transmission electron micro-
scope, FEI-Tecnai G2 spirit Biotwin, USA), and ICP-MS
(inductively coupled plasma mass spectrometer, Agilent
7500a, USA).
Photothermal Conversion Efficiency Measurement of
Silica-Modified Au Nanorods
According to the result of ICP-MS, 6.788 M Au
NR@SiO2 nanoparticles were redispersed in 1 mL final
volume of X-VIVO medium, 1 Electron Milli-Q water
respectively. Au NR@SiO2 nanoparticles in three solu-
tions mentioned above were persistently excited by a
808-nm laser (1.5 W/cm2) for 4 min, and three solutions
were treated as controls. According to this experiment, a
heating curve can be determined.
Effects of Silica-Modified Au Nanorods on Human CIK
Cells
To observe the interaction between CIK and MGC803
cells, a Leica TCS SP8 cofocal laser scanning microscopy
was applied to carry out in vitro confocal fluorescence
imaging studies. DiO perchlorate and DiI iodide were
used to label MGC803 and CIK cells, respectively. After
labeling with cell membrane dyes, they were co-
incubated for 12 h in the culture flask. DiO green fluor-
escence was excited at 488 nm with an argon ion laser,
and the emission was collected from 500 to 510 nm.
The red fluorescence of DiI was excited at 549 nm with
an argon ion laser, and the emission was collected from
560 to 570 nm.
To investigate the effects of Au NR@SiO2 on the kill-
ing activity of CIK cells, CIK cells and CIK cells labeled
with Au nanorods were respectively added into gastric
cancer cell line (MGC803) and gastric mucosal epithelial
cells (GES-1) at different ratios of effective cells to target
cells (10~50:1) and co-incubated together for different
hours. Then, the target cells were collected. An Annexin
V-FITC/PI Apoptosis Detection Kit was used to measure
the apoptotic and necrotic cells, according to the manu-
facturer’s protocol. The detection procedure worked as
described below: After coincubation, the target cells
were trypsinized, harvested, washed with 1× PBS, and
resuspended in 200 μL of 1 × binding buffer containing
5 μL Annexin V-FITC and 10 μL PI. With incubation in
dark at room temperature for 15 min, each sample was
added 400 μL of binding buffer, and the cells were im-
mediately analyzed by BD FACSCalibur (BD Biosciences,
Mountain View, CA). The data analysis was performed
with FlowJo 7.6 software. Positioning of quadrants on
Annexin V/PI plots was performed to distinguish living
cells (Annexin V −/PI −), early apoptotic cells (Annexin
V +/PI −), late apoptotic cells (Annexin V +/PI +), and
necrotic cells (Annexin V −/PI +).
CIK Cells Labeled with Au Nanorods for Targeted
Fluorescence Imaging
Firstly, gastric cancer-bearing nude mice models were
prepared. Four weeks old female BALB/c nude mice
(18–22 g) were obtained from Shanghai Slac Laboratory
Animal Co. Ltd (Shanghai, China). Collected MGC803
cells were resuspended in 1× PBS, then 2 × 106 cells/site
was subcutaneously injected in the right flank of the
mice. The tumors were allowed to grow for 3 weeks to
reach a size of ≈150–200 mm3.
Fluorescent dye DiR was applied to label the cell
membrane of human CIK cells labeled with Au nano-
rods. 5 × 106 CIK cells labeled with Au nanorods were
resuspended in 3-ml DiR working solution (concentra-
tion = 2.5 μM, fresh X-VIVO as solvent) then washed
with 1× PBS twice after incubating at 37 °C (5 % CO2)
for 20 min. The 5 × 106 DiR-labeled CIK cells loaded
with Au nanorods were resuspended in 100-μL 1× PBS
and then were injected with multi-points around the
tumor site. In vivo time-course fluorescence imaging
(excitation 748/20 nm; emission 780/10 nm; exposure
time 30 s) was performed by a Bruker In-Vivo F PRO
imaging system (Billerica, MA, USA) at 0, 1, 3, 5, and
7 days. Then, at number 3 day post-injection of CIK
cells, the mice sera in experiment group and control
group were collected, and the cytokine levels such as IL-
1, IL-12, IL-2, IL-4, IL-17, and IFN-γ were measured by
commercial ELISA kit.
CIK Cells Loaded with Au Nanorods for Targeted
Photoacoustic Imaging
CIK cells loaded with Au nanorods were used for photo-
acoustic imaging of gastric cancer-bearing nude mice
model. Gastric cancer-bearing nude mice were divided
into three groups, control number 1 group (only injec-
tion of PBS), control number 2 group (only injection of
Au nanorods (200 μg/mL)), experiment group (Au
nanorods-labeled CIK, 1 × 106 CIK cells incubated with
200 μg/mL for 24 h), which were respectively injected
with PBS, Au nanorods, and Au nanorod-labeled CIK
cells via tail veins into gastric cancer-bearing nude mice,
and the images were collected at pre-injection, 6, 12, 24,
and 72 h post-injection time point for excitation at
800 nm by NEXUS 128 photoacoustic imaging system.
Human CIK Cells Loaded with Au Nanorods for
Photothermal Therapy
1 × 106 human CIK cells and CIK cells labeled with Au
nanorods were respectively added into MGC803 gastric
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cancer cell line and gastric mucosal epithelial cells
(GES-1) at different ratios of effective cells to target cells
(10~50:1) and co-incubate for 24 h. The treatment
group was exposed to a 808-nm laser (1.5 W/cm2) for
4 min. Then, the cell viability of control and treatment
groups was analyzed by a Cell Counting Kit-8 kit.
Mice were divided into four groups (n = 5):1× PBS
(100 NVivo cell and photothermal therapy, mice were
divided into four groups (n = 5):by a cell counting ×106
per tumor) resuspended in 100 μL 1× PBS were admin-
istered by peritumoral multi-point injection method;
DiR-labeled CIK cells labeled with Au nanorods (5 × 106
per tumor) resuspended in 100 μL 1× PBS were admin-
istered for two groups by peritumoral multi-point injec-
tion method (one for 808-nm laser irradiation for), only
the mice in last group were exposed to a 808-nm laser
(1.5 W/cm2, 7 days post-injection). The temperature
changes of tumor site were recorded by an IR imaging
sensor (Testo 875i, Germany).
Biodistribution and Pathological Examination
MGC803 cells (5 × 106) were injected subcutaneously
into the right back flank area of 6- to 8-week-old female
nude mice. Tumors were allowed to grow to a diameter
of approximately 5 mm. At that point, 2 × 106 CIK cells
labeled with PEGylated Au nanorods were injected into
the mice via the tail vein. Twelve mice were divided into
four groups and then were sacrificed 1, 3, 5, and 7 weeks
later. Several hundreds of microliter blood was immedi-
ately collected from the heart, mixed with 1 mg EDTA
in microfuge tubes, and frozen in liquid nitrogen. Then,
organs were collected and frozen in liquid nitrogen.
Blood and tissue samples were completely lysed in aqua
regia. Following with evaporation process, the resulting
precipitates were dissolved in 0.5 M HCl. The Au con-
tent determination was conducted on an Agilent 7500a
and every data point was expressed as a mean ± SD
from triplicate samples. Data were represented as per-
centage of injection dose/organ.
The collected important organs were firstly fixed in
4 % neutral buffered formalin for 24 h, then dehydrated
in 30 % sucrose solution, and processed into Tissue
OCT-Freeze Medium and section. A standard H&E
(hematoxylin and eosin) staining was performed to
measure the histopathology changes of tumors.
Statistical Analysis
All data were expressed as mean ± SD (standard error)
of at least five independent experiments unless otherwise
specified. Statistical analysis was performed by Student’s
t test (p < 0.05) and was indicated to be statistical
significant.
Results and Discussion
Preparation and Characterization of Au NRs and Au
NR@SiO2
Au nanorods were synthesized by seed-mediated growth
method [34]; resultant CTAB-coated Au NRs were
modified with SiO2. CTAB formed a bilayer around the
Au NRs and served as an organic template for the for-
mation of the silica layer on the surface of Au nanorods
[36]. As shown in Fig. 1a, prepared Au nanorods have
two absorption peaks, respectively located at 520 and
810 nm, and prepared Au NR@SiO2 nanoparticles have
two absorption peaks, respectively located at 520 and
820 nm, exhibiting 10-nm red-shift. As shown in Fig. 1b,
the synthesized Au nanorods have 60 nm in length and
8 nm in width; silica shell thickness was 20 nm or so in
diameter.
Preparation and Characterization of Human CIK Cells
Cytokine-induced killer (CIK) cells are derived from per-
ipheral blood mononuclear cells (PBMCs), which are
usually obtained from the peripheral blood or cord
blood. Three cytokines were added in the course of the
cell culture: rh IFN-γ was used to induce some immune
accessory molecules secretion and enhance the anti-
tumor function of CIK cells [38]; CD3 monoclonal anti-
body was added into the culture liquid and induced
higher level of cytotoxic activity and proliferation rate of
Fig. 1 Characterization of the Au NR@SiO2 nanoparticles. a UV–vis
spectra of Au NRs and Au NR@SiO2 nanoparticles. b HRTEM images
of Au NRs and Au NR@SiO2 nanoparticles
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human CIK cells [31]; added cytokine rhIL-2 can get a
higher proliferation rate of CIK cells [32]. Schmidt-Wolf
[13] et al. reported that the higher lytic activity of CIK
cells as compared to LAK cells was mainly due to the
higher proliferation of CD3+CD56+ T cells. CD3+CD56+
T cells were demonstrated to have non-MHC-restricted
cytotoxicity and were very rare (1~5 %) in uncultured
PBMCs. After co-culture with three kinds of cytokines
for almost 3 weeks, as shown in Fig. 2a, the ratio of
CD3+CD56+ T cells increased to 41 %, which highly sug-
gest that human CIK cells including high concentration of
CD3+CD56+ cell subpopulation were successfully pre-
pared and owned a stronger anti-tumor bio-activity. As
shown in Fig. 2b, prepared Au NR@SiO2 could have been
gulfed into cytoplasm by human CIK cells. We also quan-
titatively determined the amount of Au NRs@SiO2 nano-
particles in CIK cells; the result showed that 13.576 μg Au
existed in 1 × 107 human CIK cells. As shown in Fig. 2c,
prepared Au NR@SiO2 did not inhibit growth of CIK
cells, MGC803 cells, and GES-1 cells, exhibiting low cyto-
toxicity, which fully demonstrate that Au NR@SiO2 NPs
can label human CIK cells (NP-CIK cells), and owning
good biocompatibility.
Photothermal Conversion Efficiency of Au NRs@SiO2
Au NRs@SiO2 nanoparticles have been broadly used for
photothermal therapy of tumor [28, 35, 36]. But, few re-
port is associated with human CIK cells labeled with Au
NR@SiO2 (NP-CIK cells) for tumor target imaging and
photothermal therapy. We measured the photothermal
conversion efficiency of prepared Au NR@SiO2 nanopar-
ticles under three kinds of different solvents such as
Milli-Q water, 1× PBS, and X-VIVO medium; as shown
in Fig. 3, three photothermal conversion efficiency
curves of Au NRs@SiO2 nanoparticles were obtained
(6.788 μg/ml per sample, 5 × 106 CIK cells). The vari-
ation tendency of temperature is in accordance with the
results of IR imaging (Fig. 6a). Free Au NRs@SiO2 nano-
particles can produce 60 °C under 808-nm NIR laser ir-
radiation for 4 min. The temperature value is 55 °C at
2.5 min in heating curve and it is 57 °C in IR images at
the same time point, which is enough for photothermal
Fig. 2 a Phenotype assay of cytokine-induced killer (CIK) cells: the percentage of CD3+CD56+ T cell is 41.0 % and CD3+ T cell represents more
than 90 % of collected CIK cells. b Bio-TEM image of NP-CIK cell. c Cytotoxicity assay of several concentrations of Au NRs@SiO2 versus three kinds
of cells—CIK, MGC803, and GES-1 cells
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therapy. 5 × 106 human CIK cells labeled with Au
NR@SiO2 can produce the similar high temperature of
60 °C under the same condition.
Effects of Human CIK Cells Labeled with Au NR@SiO2 on
MGC803 Cells
Current studies show that CIK cells are a heterogeneous
subset of ex vivo expanded T lymphocytes [10–12]. They
present a mixed T-NK phenotype and are endowed with
the MHC-unrestricted anti-tumor activity, which means
it can kill cancer cells without attacking the normal cells
[13, 14]. Some reports show that human CIK cells can
target in vivo tumor cells. In the course of interaction
between CIK cells and tumor cells, CIK cells exhibit kill-
ing tumor cell function. The anti-tumor mechanism of
CIK cells was as follows: inducing target tumor cell
apoptosis in the early stage and necrosis in the late stage
[39]; released some chemical factors such as NKG2D,
granzyme B, and perforin, killing tumor cells in the
process of interaction between effective cells and target
tumor cells [40].
We also investigated the effects of human CIK cells la-
beled with Au NRs@SiO2 on gastric cancer MGC803
cells. With the aim of screening out the optimal ratio of
CIK cells to gastric cancer cells, we added human CIK
cells labeled with Au NR@SiO2 into MGC803 cells as
the ratio of 10:1, 30:1, and 50:1 and then co-incubated
for 12 h. Then, we used the confocal microscopy to ob-
serve cells. As shown in Fig. 4a, CIK cells actively target
and home to the surface of MGC803 cells and then pro-
duce the anti-tumor function. As shown in Fig. 4b, hu-
man CIK cells cannot induce human normal gastric
mucous cell GES-1 appear apoptosis, conversely, human
CIK cells labeled with Au NRs@SiO2 can induce
MGC803 cells appear apoptosis. Apoptosis cell number
increased as the ratio of CIK cells to MGC803 cells
increased. When the ratio of CIK cells to MGC803 cells
reaches to 50:1, apoptosis cell number reaches to 11.2 %,
which fully demonstrates that human CIK cells labeled
with Au NR can kill gastric cancer cells via inducing cell
apoptosis, and human CIK cell does not kill normal hu-
man gastric mucous cells [41, 42].
We also used CCK-8 kit to investigate the viability of
MGC803 cells or GES-1 cells incubated with human CIK
cells labeled with Au NR or only CIK cells. As shown in
Fig. 5, human CIK cells and NP-CIK cells cannot inhibit
growth of normal gastric mucous GES-1 cells but can in-
hibit the growth of gastric cancer MGC803 cells. As the
ratio of human CIK cells to gastric cancer cells increased,
the viabilities of gastric cancer MGC803 cells became
lower and lower and was 32 %; under 1 W/cm2 808-nm
laser irradiation for 4 min, the viabilities of MGC803
cells became the lowest and was 18 %; there existed
statistical difference between the test group of NP-
CIK + laser irradiation for 4 min and the control
group of only NP-CIK treatment, P < 0.01, which fully
demonstrates that human CIK cells labeled with Au
nanorod scan enhance immunotherapeutic efficacy of
CIK cells under laser irradiation [43, 44].
CIK Cells Labeled with Au Nanorods for Targeted
Fluorescent Imaging
In order to investigate the feasibility of NP-CIK cells for
targeted fluorescent imaging of gastric cancer in vivo, we
prepared MGC803 gastric cancer-bearing nude mouse
models, and 1 × 106 NP-CIK cells were injected into nude
mouse models via tail vein. At 24 h post-injection, 22 % of
NP-CIK cells were located in gastric cancer site; as the
post-injection day increased, the amount of NP-CIK cells
in tumor site also increased; at 5 days post-injection, the
amount of NP-CIK cells reached to 28 %, which show that
NP-CIK cells can target in vivo gastric cancer cells.
In order to increase the amount of NP-CIK cells in the
site of gastric cancer in vivo, 1 × 106 NP-CIK cells labeled
with DiR dye were injected into in vivo tumor site via peri-
tumoral injection. As shown in Fig. 6, from 1 to 7 days
post-injection, tumor sites always kept strong fluorescent
signals, which show that DiR-labeled NP-CIK cells can stay
in the tumor site for a long time. The amount of NP-CIK
cells in tumor site via peritumoral injection is higher than
the amount in tumor site via tail vein injection. NP-CIK
cells enter into other organs such as the liver, spleen, lung,
kidney, and brain, protect other important organs’ function,
and own obvious advantages over tumor-targeted therapy
based on NP-CIK cells via tail vein injection.
NP-CIK Cells for Photoacoustic Imaging of Gastric Cancer
In Vivo
The 720-nm NIR laser with moderate energy (~4 mJ per
pulse) was used for photoacoustic imaging (PA) of the
Fig. 3 The heating curve of free Au NRs@SiO2 nanoparticles in
three solvents
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tumor in vivo, at which the wavelength neovasculariza-
tion (CNV) was identified and the NP-CIK cells had a
high PA contrast effect. As shown in Fig. 7, the PA sig-
nals of both NP (Fig. 7a) and NP-CIK cell (Fig. 7b)
injection groups got a trend of continuous heightening.
However, the intensity of PA signals in NP-CIK cell in-
jection group (Fig. 7b) showed a more homogeneous ef-
fect than NP injection group (Fig. 7a). From this result,
Fig. 4 a Confocal images of the interactions between CIK cells (red fluorescence) and MGC803 cells (green fluorescence). b, c The apoptosis assay
executed by flow cytometry
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we can make a conclusion that the NP-CIK cells have a
stronger ability of targeting and diffusion than simple
NP injection. Basing on the information acquired from
the PA images, the difference in the two test groups
maybe due to the active targeting of CIK cells. Although
the Au NR@SiO2 NPs also have the function to target
the tumor site via the enhanced permeability and reten-
tion (EPR) effect [43, 44], the simple nanoparticles can-
not obtain a higher efficiency of targeting than NP-CIK
cell complex peritumor injection.
In Vivo Biodistribution of CIK Cells Labeled with Au NRs
As shown in Fig. 8, after NP-CIK cells were injected
into gastric cancer-bearing nude mouse models via tail
vein injection, at 24 h post-injection, almost 40 % of
NP-CIK cells were located in gastric cancer site; as the
post-injection day increased, the amount of NP-CIK
cells in the tumor site became more and more, at 5 days
post-injection, it reached to 28 %, and at 7 days post-
injection, it reached to 25 %, which show that NP-CIK
cells can target in vivo gastric cancer tissues. In
addition, NP-CIK cells also enter into the liver, spleen,
kidney, etc.; however, compared with available reports,
the amount of gold nanorods loaded with human CIK
cells in the tumor site is higher than the amount of
antibody-conjugated gold nanorods, which show that
human CIK cells should be a good delivery system for
multifunctional nanoparticles, therapeutic gene, or
drugs.
CIK Cells Labeled with Au Nanorods for Gastric Cancer
Immunotherapy
As shown in Fig. 9, there is no statistical difference in
serum levels of cytokines such as IL-1, IL-12, and IL-2
between the experiment groups and control groups at
3 days post-injection, which suggested that no negative
inflammatory reaction occurred in experiment groups
and the immune safety also was proved unambiguously.
Moreover, a statistically distinct increase of serum levels
of IL-4, IL-17, and IFN-γ is observed in experiment
groups compared with control groups (P < 0.05), which
indicated that the innate immune was enhanced obvi-
ously in experiment groups because of the activation of
immune cells, especially to CIK cells, induced by IL-4,
IL-17, and IFN-γ.
CIK Cells Labeled with Au NRs for Photothermal Therapy
As shown in Fig. 10, from the IR images, the NP-CIK
cells induced obvious elevation of temperature in the
tumor site while no visible changes happened in other
groups. According to the bar value, at 1.5 min post-
injection, the temperature of the tumor site achieved
57 °C, which is enough to kill tumor cells.
As shown in Fig. 11, from the histological analysis, the
synergistic anti-cancer effects (Fig. 11a) based on NP-based
photothermal therapy and CIK cell-based immunotherapy
Fig. 5 CCK-8 assay for CIK immunotherapy and photothermal therapy efficacy. a GES-1 cells were treated as the control group. b MGC803 cells
were treated under four conditions
Fig. 6 In vivo fluorescence imaging of NP-CIK and CIK cells. a, b NP-CIK
cells injected. c CIK cells injected. d 1× PBS injected as control
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is better than that the effects based on only photothermal
therapy (Fig. 11b) or immunotherapy (Fig. 11c). According
to this result, CIK cell-based immunotherapy combined
with Au NR-based photothermal therapy remarkably en-
hances the synergistic therapeutic efficacy, which will be a
promising treatment for gastric cancer.
We also prepared subcutaneous gastric cancer-bearing
nude mouse models and raised nude models for 3 weeks.
The tumor volume reached to 150–200 mm3. When
NP-CIK cells were injected into the tumor sites, as
shown in Fig. 12, NP-CIK cells + 1.5 W/cm2 laser irradi-
ation group obviously inhibited the growth of tumor tis-
sues, which make the tumor size smaller and smaller,
compared with only CIK treatment group or Au
NR@SiO2 + laser irradiation group. There existed statis-
tical difference (P < 0.01). NP-CIK cells exhibit better
therapeutic effects. Peritumor injection of NP-CIK cells
should be a better choice compared with targeted ther-
apy based on tail vein injection and have great potential
in applications such as tumor therapy in the near future.
Conclusions
In summary, we successfully prepared for the first time
the CIK cells labeled with Au nanorods and realized tar-
geted gastric cancer fluorescent imaging, photoacoustic
imaging, enhanced immunotherapy, and photothermal
Fig. 7 Photoacoustic (PA) images. a Au NR@SiO2 nanoparticles contained 6.788 μg Au resuspended in 100 μL 1× PBS via peritumor injection.
b 5 × 106 NP-CIK cells resuspended in 100 μL 1× PBS via peritumor injection (which contain 6.788 μg Au). (Control) 1× PBS (100 μL) injection as
control. (day 0: before injection; day 1~4: four time points after injection)
Fig. 8 In vivo distribution of CIK cells labeled with Au NRs
Fig. 9 Cytokine concentration at 3 days post-injection of CIK cells
labeled with Au nanorods
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therapy. Human CIK cells labeled with Au nanorods can
target and gather in vivo gastric cancer tissues at 24 h
post-injection. As the time post-injection increased, the
amount of NP-CIK cells in tumor sites also increased,
but there are still NP-CIK cells located in liver, spleen,
kidney, and lung organs. Up to date, those NP-CIK cells
in liver, spleen, lung, and kidney organs show how to in-
fluence their function, which is not still clear, and needs
further investigation. As the contrast, NP-CIK cells in
tumor site via peritumor injection can stay in tumor
sites for a long time, produce better therapeutic efficacy,
combined with photothermal therapy of Au nanorods,
and exhibit enhanced inhibition of growth of tumor.
NP-CIK cells’ peritumor injection may be a better treat-
ment method choice. Due to Au nanorods’ good bio-
compatibility, therefore, human CIK cells labeled with
Au nanorods have their own clinical translation pro-
spect. Furthermore, human CIK cells with Au nanorods
designed here are a universal multifunctional theranos-
tic platform [45]. The Au nanorods can be replaced by
other nanoparticles with imaging or cancer-killing abil-
ity. The human CIK cells in the “CIK-NPs” mode act as
a “vehicle,” carrying functional nanoparticles or drugs
accurately to the tumor site [46]. Human CIK cells with
Au nanorods have great potential in applications such
Fig. 10 IR images under 1 W/cm2 808-nm NIR laser irradiation. a The tumor-bearing mice injected with NP-CIK cells. b CIK cell injection group. Con-
trol group: 1× PBS injection
Fig. 11 Histological staining of the excised tumors after 808-nm
laser irradiation (1.5 W/cm2 for 4 min). a NP-CIK cell injection with
NIR laser irradiation. b NP-CIK cell injection without laser irradiation.
c CIK cell injection with laser irradiation. d 1× PBS injection with laser
irradiation. Scale bar is 10 μm Fig. 12 Tumor time-volume curve under different treatment conditions
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as photoacoustic imaging, immunotherapy, and photo-
thermal therapy of gastric cancer and other tumors in
the near future.
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